Buyback Completed as Promised: Bud Genius Announces New Lower Outstanding and Authorized Shares - More Buybacks Planned
September 18 2014 - 7:37AM
Business Wire
The directors of Rightsmile, Inc., also known as Bud Genius,
Inc., have successfully completed a reduction of nearly 5% of the
outstanding and authorized shares of the company’s common stock.
Following the completion of a share buyback, the board passed a
resolution to lower the authorized shares of the company's common
stock by 4.99% following a stock buyback, which was confirmed by
the stock transfer agent yesterday. The company will continue its
repurchase efforts.
CEO Angel Stanz had this to say: “In the past we had to do some
drastic things to secure our funding, but now we are in a much
better position and we can use our new subsidiary to leverage our
stock. I want to buy more. The outstanding shares of the company
are too high, we will continue to work on it, and we will continue
to lower the authorized shares every time we make progress. We have
a lot more to do, and I intend to take advantage of the opportunity
now to buy our stock back at a strong price advantage.”
Copies of the completed resolution have been received by the
Transfer Agent and have been sent to OTC Markets for reporting. The
updates will be recorded at the state following the completion of
other pending stock buybacks and will be shown in the company’s SEC
filings in the next quarterly report.
About Bud Genius
An early leader in an industry that many are speculating will
grow, Bud Genius is one of the first established analytical
cannabis laboratories in the United States. Bud Genius was launched
to bring vendors together with doctors, patients, and dispensaries
that require certified products held to demanding standards. Bud
Genius has a vision to expand across the US and abroad serving as
the beacon of quality for medical cannabis and adult-use marijuana
through the formation of regional laboratories. Certification, data
collection, and online reports are the measure by which the company
gains.
For more information please visit:http://www.BudGenius.com
The foregoing press announcement contains forward-looking
statements that can be identified by such terminology such as
"believes," "expects," "potential," "plans," "suggests," "may,"
"should," "could," "intends," or similar expressions. Such
forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results
to be materially different from any future results, performance or
achievements expressed or implied by such statements. In
particular, management's expectations could be affected by, among
other things, uncertainties relating to our success in completing
acquisitions, financing our operations, entering into strategic
partnerships, engaging management and other matters disclosed by us
in our public filings from time to time. Forward-looking statements
speak only as to the date they are made. The Company does not
undertake to update forward-looking statements to reflect
circumstances or events that occur after the date the
forward-looking statements are made.
Bud GeniusAngel Stanz, 855-723-3283Chief Executive
OfficerPR@BudGenius.com
RightSmile (CE) (USOTC:RIGH)
Historical Stock Chart
From Mar 2024 to Apr 2024
RightSmile (CE) (USOTC:RIGH)
Historical Stock Chart
From Apr 2023 to Apr 2024